Cargando...

Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo

The reduced efficiency with which herpes simplex virus type 1 (HSV-1) mutants establish latent infections in vivo has been a fundamental obstacle in efforts to determine the roles of individual viral genes in HSV-1 reactivation. For example, in the absence of the “nonessential” viral immediate-early...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Halford, William P., Schaffer, Priscilla A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2000
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC112092/
https://ncbi.nlm.nih.gov/pubmed/10846077
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!